DVAX

DYNAVAX TECHNOLOGIES CORP

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001029142
Vol
Inst. Holders8 funds
Inst. Value$260.1M
Inst. Activity1 buys / 2 sells
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001029142

Recent Activity

May 4, 2026 earnings_calendar
DVAX Q1 2026 Earnings Scheduled — 2026-05-04
Feb 10, 2026 Insider
CANO FRANCIS sold 25,000 shares
Director @ $0.00 ($0.00)
Feb 10, 2026 Insider
CANO FRANCIS sold 42,663 shares
Director @ $0.00 ($0.00)
Feb 10, 2026 Insider
Slebir John L sold 16,666 shares
SVP General Counsel @ $0.00 ($0.00)
Inst.
BANK OF AMERICA CORP — TRIM
1,057,175 shares ($16.3M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
114,449 shares ($1.8M)

Analyst Ratings

Historical distribution78% buy · 9 analysts · last covering-analyst action Dec 2025
2Strong Buy
5Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Dec 24, 2025 William Blair DOWNGRADE Outperform → Market Perform
Aug 22, 2025 JMP Securities REITERATE Market Outperform → Market Outperform
Aug 8, 2025 JMP Securities MAINTAIN Market Outperform → Market Outperform
May 7, 2025 JMP Securities MAINTAIN Market Outperform → Market Outperform
Apr 17, 2025 Goldman Sachs MAINTAIN Sell → Sell

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$123.5M
RENAISSANCE TECHNOLOGIES LLC$51.3M
MORGAN STANLEY$25.4MTRIM
TWO SIGMA INVESTMENTS, LP$25.1MADD
BANK OF AMERICA CORP$16.3MTRIM

Recent Insider Trades

DateInsiderTypeValue
Feb 10, 2026CANO FRANCISD$0.00
Feb 10, 2026CANO FRANCISD$0.00
Feb 10, 2026Slebir JohnD$0.00
Feb 10, 2026Slebir JohnD$0.00
Feb 10, 2026Slebir JohnD$0.00
8 institutional holders with $260.1M total value (16,909,047 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net selling activity: 2 institutions trimmed/exited vs 1 added.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC8,027,448$123.5M47.5%
2RENAISSANCE TECHNOLOGIES LLC3,337,533$51.3M19.7%
3MORGAN STANLEY1,653,993$25.4M9.8%TRIM -33.0%
4TWO SIGMA INVESTMENTS, LP1,632,610$25.1M9.7%ADD +40.9%
5BANK OF AMERICA CORP /DE/1,057,175$16.3M6.3%TRIM -27.5%
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC980,711$15.1M5.8%NEW
7WELLS FARGO & COMPANY/MN114,449$1.8M0.7%ADD +63.5%
8FMR LLC105,128$1.6M0.6%TRIM -44.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/TRIM1,458,0871,057,175-27.5%$16.3M2025-Q4
WELLS FARGO & COMPANY/MNADD69,990114,449+63.5%$1.8M2025-Q4
FMR LLCTRIM187,861105,128-44.0%$1.6M2025-Q4
BANK OF AMERICA CORP /DE/ADD1,159,9811,458,087+25.7%$14.5M2025-Q3
WELLS FARGO & COMPANY/MNTRIM141,43169,990-50.5%$695.0K2025-Q3
TWO SIGMA INVESTMENTS, LPADD1,316,0631,854,407+40.9%$18.4M2025-Q2
MORGAN STANLEYTRIM2,485,1921,664,340-33.0%$16.5M2025-Q2
BANK OF AMERICA CORP /DE/ADD878,8771,159,981+32.0%$11.5M2025-Q2
UBS Group AGTRIM542,098405,868-25.1%$4.0M2025-Q2
MORGAN STANLEYTRIM3,491,3292,485,192-28.8%$32.2M2025-Q1
TWO SIGMA INVESTMENTS, LPADD866,3561,316,063+51.9%$17.1M2025-Q1
CITADEL ADVISORS LLCDOUBLED95,994705,683+635.1%$9.2M2025-Q1
UBS Group AGDOUBLED250,859542,098+116.1%$7.0M2025-Q1
WELLS FARGO & COMPANY/MNDOUBLED67,806185,728+173.9%$2.4M2025-Q1
FMR LLCDOUBLED61,136183,238+199.7%$2.4M2025-Q1
NORGES BANKEXIT607,8000-100.0%$0.002025-Q1
NORGES BANKNEW607,800$7.8M2024-Q4
CITADEL ADVISORS LLCNEAR_EXIT576,46195,994-83.3%$1.2M2024-Q4
WELLS FARGO & COMPANY/MNADD50,57667,806+34.1%$865.9K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW1,122,733$12.5M2024-Q3
13 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Feb 10, 2026CANO FRANCISDirectorD25,000$0.00$0.00
Feb 10, 2026CANO FRANCISDirectorD42,663$0.00$0.00
Feb 10, 2026Slebir John LSVP General CounselD16,666$0.00$0.00
Feb 10, 2026Slebir John LSVP General CounselD300,000$0.00$0.00
Feb 10, 2026Slebir John LSVP General CounselD50,000$0.00$0.00
Feb 10, 2026Slebir John LSVP General CounselA50,000$0.00$0.00
Feb 10, 2026Slebir John LSVP General CounselU69,634$0.00$0.00
Feb 10, 2026Metzinger Joseph AnthonyVP, Chief Accounting OfficerD25,455$0.00$0.00
Feb 10, 2026Metzinger Joseph AnthonyVP, Chief Accounting OfficerD31,500$0.00$0.00
Feb 10, 2026Metzinger Joseph AnthonyVP, Chief Accounting OfficerU7,129$0.00$0.00
Feb 10, 2026SILVERNAIL LAUREN PDirectorD42,750$0.00$0.00
Feb 10, 2026SILVERNAIL LAUREN PDirectorD10,075$0.00$0.00
Feb 10, 2026Myers Scott DunsethDirectorD45,000$0.00$0.00
Feb 10, 2026Myers Scott DunsethDirectorD31,204$0.00$0.00
Feb 10, 2026Myers Scott DunsethDirectorU3,800$0.00$0.00
Feb 10, 2026Novack David FPresident & COOD67,860$0.00$0.00
Feb 10, 2026Novack David FPresident & COOA67,860$0.00$0.00
Feb 10, 2026Novack David FPresident & COOU63,334$0.00$0.00
Feb 10, 2026Novack David FPresident & COOD22,620$0.00$0.00
Feb 10, 2026Novack David FPresident & COOD150,000$0.00$0.00
Feb 10, 2026Sun Elaine DDirectorD45,000$0.00$0.00
Feb 10, 2026Sun Elaine DDirectorD29,865$0.00$0.00
Feb 10, 2026Spencer RyanCEO and DirectorD55,000$0.00$0.00
Feb 10, 2026Spencer RyanCEO and DirectorD50,000$0.00$0.00
Feb 10, 2026Spencer RyanCEO and DirectorD165,000$0.00$0.00
Feb 10, 2026Spencer RyanCEO and DirectorA165,000$0.00$0.00
Feb 10, 2026Spencer RyanCEO and DirectorU379,620$0.00$0.00
Feb 10, 2026MacGregor BrentDirectorD50,000$0.00$0.00
Feb 10, 2026MacGregor BrentDirectorD21,829$0.00$0.00
Feb 10, 2026MacDonald KellySVP and CFOA46,430$0.00$0.00
Feb 10, 2026MacDonald KellySVP and CFOU60,204$0.00$0.00
Feb 10, 2026MacDonald KellySVP and CFOD350,000$0.00$0.00
Feb 10, 2026MacDonald KellySVP and CFOD46,430$0.00$0.00
Feb 10, 2026KISNER DANIEL LDirectorD25,000$0.00$0.00
Feb 10, 2026KISNER DANIEL LDirectorD15,000$0.00$0.00
Feb 10, 2026KISNER DANIEL LDirectorD21,829$0.00$0.00
Feb 10, 2026KISNER DANIEL LDirectorU1,500$0.00$0.00
Feb 10, 2026Emini EmilioDirectorD42,750$0.00$0.00
Feb 10, 2026Emini EmilioDirectorD10,075$0.00$0.00
Feb 10, 2026Deep Track Biotechnology Master Fund, Ltd.10%+ OwnerU15,726,349$0.00$0.00
Feb 10, 2026MacDonald KellySVP and CFOD15,476$0.00$0.00

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Dec 2025): 78% buy across 9 analysts — 2 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
9 analyst firms have rated this stock: 5 upgrades, 5 downgrades, 6 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Dec 24, 2025 William Blair DOWNGRADE Outperform Market Perform
Aug 22, 2025 JMP Securities REITERATE Market Outperform Market Outperform
Aug 8, 2025 JMP Securities MAINTAIN Market Outperform Market Outperform
May 7, 2025 JMP Securities MAINTAIN Market Outperform Market Outperform
Apr 17, 2025 Goldman Sachs MAINTAIN Sell Sell
Feb 21, 2025 Citizens Capital Markets MAINTAIN Market Outperform Market Outperform
Feb 21, 2025 HC Wainwright & Co. REITERATE Buy Buy
Feb 11, 2025 Goldman Sachs DOWNGRADE Neutral Sell
Jan 14, 2025 HC Wainwright & Co. MAINTAIN Buy Buy
Nov 8, 2024 HC Wainwright & Co. REITERATE Buy Buy
Oct 15, 2024 HC Wainwright & Co. REITERATE Buy Buy
Aug 8, 2024 Goldman Sachs MAINTAIN Neutral Neutral
Aug 7, 2024 HC Wainwright & Co. REITERATE Buy Buy
Jun 28, 2024 HC Wainwright & Co. REITERATE Buy Buy
May 14, 2024 HC Wainwright & Co. REITERATE Buy Buy
May 9, 2024 HC Wainwright & Co. REITERATE Buy Buy
Feb 1, 2024 Goldman Sachs INITIATE Neutral
Nov 3, 2023 JMP Securities MAINTAIN Market Outperform Market Outperform
Nov 3, 2023 HC Wainwright & Co. MAINTAIN Buy Buy
Aug 4, 2023 HC Wainwright & Co. REITERATE Buy Buy
Aug 4, 2023 JMP Securities MAINTAIN Outperform Outperform
May 3, 2023 JMP Securities MAINTAIN Outperform
May 3, 2023 HC Wainwright & Co. REITERATE Buy
Feb 24, 2023 JMP Securities MAINTAIN Market Outperform
Feb 24, 2023 HC Wainwright & Co. MAINTAIN Buy
Nov 4, 2022 Goldman Sachs MAINTAIN Buy
Sep 27, 2022 JMP Securities INITIATE Market Outperform
Dec 29, 2021 HC Wainwright & Co. MAINTAIN Buy
Aug 31, 2021 HC Wainwright & Co. MAINTAIN Buy
Aug 6, 2021 Goldman Sachs INITIATE Buy
Aug 5, 2021 HC Wainwright & Co. MAINTAIN Buy
Feb 1, 2021 HC Wainwright & Co. MAINTAIN Buy
Nov 6, 2020 HC Wainwright & Co. MAINTAIN Buy
Aug 7, 2020 HC Wainwright & Co. MAINTAIN Buy
Aug 3, 2020 HC Wainwright & Co. MAINTAIN Buy
Mar 12, 2020 HC Wainwright & Co. REITERATE Buy
Oct 18, 2019 HC Wainwright & Co. INITIATE Buy
Jul 11, 2019 Cantor Fitzgerald UPGRADE Neutral Overweight
Nov 6, 2018 RBC Capital MAINTAIN Outperform Outperform
May 10, 2018 JP Morgan UPGRADE Neutral Overweight
Feb 14, 2018 JP Morgan MAINTAIN Neutral Neutral
Feb 14, 2018 JP Morgan DOWNGRADE Overweight Neutral
Nov 10, 2017 Cantor Fitzgerald MAINTAIN Overweight
Sep 15, 2017 Cantor Fitzgerald INITIATE Overweight
Jul 31, 2017 RBC Capital UPGRADE Sector Perform Outperform
Apr 28, 2016 RBC Capital DOWNGRADE Outperform Sector Perform
Apr 27, 2016 JP Morgan DOWNGRADE Overweight Neutral
Nov 30, 2015 RBC Capital INITIATE Outperform
Mar 23, 2015 JP Morgan UPGRADE Neutral Overweight
Nov 25, 2013 McNicoll Lewis Vlak UPGRADE Hold Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262520078%
May 1, 20262520078%
Apr 1, 20262520078%
Mar 1, 20262520078%
Feb 1, 20262520078%
Jan 1, 20262520078%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 4, 2026
earnings_calendar
DVAX Q1 2026 Earnings Scheduled — 2026-05-04
Feb 10, 2026
short_interest
FTD: DVAX — 1,588,257 shares ($24.6M) failed to deliver
Settlement: 20260210, Price: $15.50, FTD Value: $24,617,983.5, DYNAVAX TECHNOLOGIES CORP COM